【摘 要】
：
Gastric cancer (GC) is one of the main causes of cancer death in Europe.In Japan,the well-conducted screening programmes significantly decreased the rate of mortality but the incidence is still increa
【机 构】
：
Research Laboratory of the Department of Pathology University of Medicine and Pharmacy of Tirgu-Mure
论文部分内容阅读
Gastric cancer (GC) is one of the main causes of cancer death in Europe.In Japan,the well-conducted screening programmes significantly decreased the rate of mortality but the incidence is still increasing.
其他文献
Lung Cancer is the most frequent cancer worldwide with more than 1,3 M new case each year.The years 2000 saw two major changes in lung cancer,the predominance of adenocarcinoma and a personalized trea
The aim of this study was to evaluate the clinical activity of another angiogenesis inhibitor Endostar (rh-endostatin) in combination with continued EGFR-TKIs (including erlotinib,gefitinib and icotin
Lung cancer in never smokers patients is on the seventh rank,the most common cause of cancer-related mortality,then it is followed by cancers of the cervix,pancreas,and prostate.
The overexpression of epidermal growth factor receptor (EGFR) is closely associated with a poor outcome in non-small cell lung cancer (NSCLC),and EGFR is an ideal biomarker for the targeted therapy of
Background: The incidence of multiple primary malignancies (MPM) has increased sharply in recent decades.However,the clinical characteristics and prognosis of MPM patients involving lung cancer were n
Lung cancer is the most common cause of cancer death in developed countries.The prognosis is poor,with less than 15% of patients surviving 5 years after diagnosis.
Advanced non-small-cell lung cancer (NSCLC) is a heterogeneous and difficult-to-treat disease.Advances in the understanding of N SCLC pathogenesis have led to identification of molecular "drivers" of
Small cell lung cancer represents about 13-18% of all lung cancers.It is characterized by early metastases and high mortality.It is important to remember that a small percentage of patients presenting
The concept that pluripotent cancer stem cells (CSCs) are involved in the development and progression of many types of malignancies,including colorectal cancer (CRC),is now well accepted.
The potential disadvantages of blood transfusion during curative gastrectomy for gastric cancer were reported,and the role of peri-operative blood transfusion remained to be ascertained.